Additional non-oral contraception is advised for 4 weeks after starting treatment and for 4 weeks after each dose increase If pancreatitis is suspected (severe, persistent abdominal pain with or without vomiting), stop Mounjaro immediately and seek urgent medical assessment Mounjaro is not indicated for type 1 diabetes or diabetic ketoacidosis The medication is not recommended during pregnancy or breastfeeding Patients should report any suspected side effects via the MHRA Yellow Card Scheme
The standard regimen involves weekly self-administered injections, with dose adjustments made by your medical provider as needed throughout the program
23,24 Long-term follow-up studies indicate that the incidence of osteoporosis in IBD patients is higher than that in the control population, with around 14.2%20.1% of IBD patients and 6.6% of the control group being diagnosed with osteoporosis
This is for information only and should not be a substitute for seeking medical advice
In conclusion, this work offers insights into the interplay between Bbs5 deficiency, humoral and immune signaling, and metabolic dysregulation